Your browser doesn't support javascript.
loading
Prevalence and predictors of treatment-resistant schizophrenia in a tertiary hospital in Northeast Brazil.
Soares, Douglas de Sousa; Carvalho, Danyelle Rolim; Ribeiro, Mellanie Dellylah Trinta; Diniz, Elton Jorge Bessa; Rêgo, Alcides Ferreira.
Affiliation
  • Soares DS; Programa de Residência Médica em Psiquiatria, Hospital de Saúde Mental Professor Frota Pinto, Fortaleza, CE, Brazil.
  • Carvalho DR; Programa de Residência Médica em Psiquiatria, Hospital de Saúde Mental Professor Frota Pinto, Fortaleza, CE, Brazil.
  • Ribeiro MDT; Programa de Residência Médica em Psiquiatria, Hospital de Saúde Mental Professor Frota Pinto, Fortaleza, CE, Brazil.
  • Diniz EJB; Programa de Esquizofrenia (PROESQ), Departamento de Psiquiatria, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil. Laboratório Interdisciplinar de Neurociências Clínicas (LiNC), Departamento de Psiquiatria, UNIFESP, São Paulo, SP, Brazil.
  • Rêgo AF; Programa de Residência Médica em Psiquiatria, Hospital de Saúde Mental Professor Frota Pinto, Fortaleza, CE, Brazil.
Article in En | MEDLINE | ID: mdl-34139114
ABSTRACT

OBJECTIVE:

To investigate epidemiological factors related to treatment-resistant schizophrenia (TRS) in Northeast Brazil, a region where data about mental health are still scarce.

METHODS:

This retrospective cross-sectional study included all patients with schizophrenia currently receiving treatment at the outpatient psychiatric clinic of a tertiary hospital in Northeast Brazil. They were divided into TRS and treatment-responsive groups, and epidemiological characteristics of both groups were compared. A logistic regression model investigated factors related to treatment resistance.

RESULTS:

Two hundred and five patients were included, 155 treatment-resistant and 50 treatment-responsive. The TRS group had higher use of benzodiazepines (36.1 vs. 18%, p = 0.017) and antiepileptics (36.8 vs. 8.0%, p < 0.001), antipsychotic polypharmacy (28.6 vs. 8%, p = 0.003) and suicide attempts (35.6 vs. 20%, p = 0.04). Age at onset was younger (19.7±7.3 vs. 24.6±8.6 years, p = 0.001) and CGI was higher in TRS (3.72±1.00 vs. 3.16±1.00, p = 0.001). In logistic regression, being married was a protector (odds ratio [OR] = 0.248, 95% confidence interval [95%CI] 0.091-0.679, p = 0.007) and younger age at onset was a predictor (OR = 1.076, 95%CI 1.034-1.120, p < 0.001) of treatment resistance.

CONCLUSION:

Early onset of disease was associated with more treatment resistance, while being married with less resistance. Clinicians should identify early predictors of resistance in order to reduce unfavorable outcomes.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Country/Region as subject: America do sul / Brasil Language: En Journal: Trends Psychiatry Psychother Year: 2021 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Country/Region as subject: America do sul / Brasil Language: En Journal: Trends Psychiatry Psychother Year: 2021 Document type: Article Affiliation country: